Identifying serotonergic mechanisms underlying the corticolimbic response to threat in humans

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 368, Issue 1615, 2013, Pages

  Fisher, Patrick M ^a   Hariri, Ahmad R ^b,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Laboratory of Neurogenetics   (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

Amygdala; Corticolimbic; Neuroimaging; Prefrontal cortex; Serotonin; Threat

Indexed keywords

BRAIN; DISEASE TREATMENT; FUNCTIONAL ROLE; GENETICS; HEALTH RISK; HORMONE; MENTAL HEALTH; NEUROLOGY; PHYSIOLOGY; PSYCHOLOGY; PUBLIC HEALTH; SIGNALING; TOMOGRAPHY;

ANTIDEPRESSANT AGENT; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

AMYGDALOID NUCLEUS; DEPRESSION; DRUG EFFECT; FEAR; HUMAN; METABOLISM; NERVE TRACT; NEUROIMAGING; PATHOPHYSIOLOGY; PERSONALITY; PHYSIOLOGY; PREFRONTAL CORTEX; PROTEIN BINDING; REVIEW;

AMYGDALA; ANTIDEPRESSIVE AGENTS; DEPRESSION; FEAR; HUMANS; NEURAL PATHWAYS; NEUROIMAGING; PERSONALITY; PREFRONTAL CORTEX; PROTEIN BINDING; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 84874550677     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2012.0192     Document Type: Review

References (88)

1. First MB, Spitzer RL, Gibbon M, Williams JBW. 1996 Structured clinical interview for DSM-IV axis I disorders: research version, non-patient edition. New York, NY: New York State Psychiatric Institute, Biometrics Research Department.
2. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. 2005 Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiat. 62, 617-627. (doi:10.1001/archpsyc.62.6.617)
3. Greenberg PE, Kessler RC, Nells TL, Finkelstein SN, Berndt ER. 1996 Depression in the workplace: an economic perspective. In Selective serotonin reuptake inhibtors: advances in basic reserach and clinical practice (eds JP Feighner, WF Boyer), pp. 327-363. New York, NY: John Wiley & Sons Inc.
4. Trivedi MH et al. 2006 Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am. J. Psychiat. 163, 28-40. (doi:10.1176/appi.ajp.163.1.28)
5. Kessler RC. 1997 The effects of stressful life events on depression. Annu. Rev. Psychol. 48, 191-214. (doi:10.1146/annurev.psych.48.1.191)
6. Kendler KS, Gatz M, Gardner CO, Pedersen NL. 2006 Personality and major depression: a Swedish longitudinal, population-based twin study. Arch. Gen. Psychiat. 63, 1113-1120. (doi:10.1001/archpsyc.63.10.1113)
7. Kendler KS, Karkowski LM, Prescott CA. 1999 Causal relationship between stressful life events and the onset of major depression. Am. J. Psychiat. 156, 837-841.
8. Kotov R, Gamez W, Schmidt F, Watson D. 2010 Linking 'big' personality traits to anxiety, depressive, and substance use disorders: a meta-analysis. Psychol. Bull. 136, 768-821. (doi:10.1037/a0020327)
9. Hariri AR. 2009 The neurobiology of individual differences in complex behavioral traits. Annu. Rev. Neurosci. 32, 225-247. (doi:10.1146/annurev.neuro.051508.135335)
10. LeDoux JE. 2000 Emotion circuits in the brain. Annu. Rev. Neurosci. 23, 155-184. (doi:10.1146/annurev.neuro.23.1.155)
11. Davis M, Whalen PJ. 2001 The amygdala: vigilance and emotion. Mol. Psychiat. 6, 13-34. (doi:10.1038/sj.mp.4000812)
12. LeDoux J. 2007 The amygdala. Curr. Biol. 17, R868-R874. (doi:10.1016/j.cub.2007.08.005)
13. Whalen PJ. 2007 The uncertainty of it all. Trends Cogn. Sci. 11, 499. (doi:10.1016/j.tics.2007. 08.016)
14. Etkin A, Klemenhagen KC, Dudman JT, Rogan MT, Hen R, Kandel ER, Hirsch J. 2004 Individual differences in trait anxiety predict the response of the basolateral amygdala to unconsciously processed fearful faces. Neuron 44, 1043-1055. (doi:10.1016/j.neuron.2004.12.006)
15. Haas BW, Kazufumi K, Todd CR, Canli T. 2007 Emotional conflict and neuroticism: personalitydependent activation in the amygdala and sugenual anterior cingulate. Behav. Neurosci. 121, 249-256. (doi:10.1037/0735-7044.121.2.249)
16. Stein MB, Simmons AN, Feinstein JS, Paulus MP. 2007 Increased amygdala and insula activation during emotion processing in anxiety-prone subjects. Am. J. Psychiat. 164, 318-327. (doi:10.1176/appi.ajp.164.2.318)
17. Fakra E et al. 2009 Effects of HTR1A C(-1019)G on amygdala reactivity and trait anxiety. Arch. Gen. Psychiat. 66, 33-40. (doi:10.1001/archpsyc.66.1.33)
18. Drevets WC. 1999 Prefrontal cortical-amygdalar metabolism in major depression. Ann. N Y Acad. Sci. 877, 614-637. (doi:10.1111/j.1749-6632.1999.tb09292.x)
19. Mayberg HS. 2003 Modulating dysfunctional limbiccortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br. Med. Bull. 65, 193-207. (doi:10.1093/bmb/65.1.193)
20. Phillips ML, Drevets WC, Rauch SL, Lane R. 2003 Neurobiology of emotion perception. II. Implications for major psychiatric disorders. Biol. Psychiat. 54, 515-528. (doi:10.1016/S0006-3223(03)00171-9)
21. Wood JN, Grafman J. 2003 Human prefrontal cortex: processing and representational perspectives. Nat. Rev. Neurosci. 4, 139. (doi:10.1038/nrn1033)
22. Kim MJ, Loucks RA, Palmer AL, Brown AC, Solomon KM, Marchante AN, Whalen PJ. 2011 The structural and functional connectivity of the amygdala: from normal emotion to pathological anxiety. Behav. Brain Res. 223, 403-410. (doi:10.1016/j.bbr.2011.04.025)
23. McEwen BS. 2007 Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 87, 873-904. (doi:10.1152/physrev.00041.2006)
24. Quirk GJ, Mueller D. 2008 Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 33, 56-72. (doi:10.1038/sj.npp.1301555)
25. Buckholtz JW et al. 2008 Genetic variation in MAOA modulates ventromedial prefrontal circuitry mediating individual differences in human personality. Mol. Psychiat. 13, 313-324. (doi:10.1038/sj.mp.4002020)
26. Kim MJ, Gee DG, Loucks RA, Davis FC, Whalen PJ. 2010 Anxiety dissociates dorsal and ventral medial prefrontal cortex functional connectivity with the amygdala at rest. Cereb. Cortex 21, 1667-1673. (doi:10.1093/cercor/bhq237)
27. Kim MJ, Whalen PJ. 2009 The structural integrity of an amygdala-prefrontal pathway predicts trait anxiety. J. Neurosci. 29, 11614-11618. (doi:10.1523/JNEUROSCI.2335-09.2009)
28. Milad MR, Wright CI, Orr SP, Pitman RK, Quirk GJ, Rauch SL. 2007 Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. Biol. Psychiat. 62, 446-454. (doi:10.1016/j.biopsych.2006.10.011)
29. Pezawas L et al. 2005 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat. Neurosci. 8, 828-834. (doi:10.1038/nn1463)
30. Phelps EA, Delgado MR, Nearing KI, LeDoux JE. 2004 Extinction learning in humans: role of the amygdala and vmPFC. Neuron 43, 897. (doi:10.1016/j.neuron.2004.08.042)
31. Drevets WC, Price JL, Simpson JR, Todd RD, Reich T, Vannier M, Raichle ME. 1997 Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386, 824. (doi:10.1038/386824a0)
32. Sheline YI. 2003 Neuroimaging studies of mood disorder effects on the brain. Biol. Psychiat. 54, 338-352. (doi:10.1016/S0006-3223(03)00347-0)
33. Sheline YI, Gado MH, Price JL. 1998 Amygdala core nuclei volumes are decreased in recurrent major depression. Neuroreport 9, 2023-2028. (doi:10.1097/00001756-199806220-00021)
34. Whalen PJ, Shin LM, Somerville LH, McLean AA, Kim H. 2002 Functional neuroimaging studies of the amygdala in depression. Semin. Clin. Neuropsychiat. 7, 234-242. (doi:10.1053/scnp.2002.35219)
35. Blier P, de Montigny C. 1998 Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses. Biol. Psychiat. 44, 313-323. (doi:10.1016/S0006-3223(98)00114-0)
36. Hariri AR, Holmes A. 2006 Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn. Sci. 10, 182-191. (doi:10.1016/j.tics.2006.02.011)
37. Lucki I. 1998 The spectrum of behaviors influenced by serotonin. Biol. Psychiat. 44, 151-162. (doi:10.1016/S0006-3223(98)00139-5)
38. Jacobs BL, Azmitia EC. 1992 Structure and function of the brain serotonin system. Physiol. Rev. 72, 165-229.
39. Forster GL, Feng N, Watt MJ, Korzan WJ, Mouw NJ, Summers CH, Renner KJ. 2006 Corticotropinreleasing factor in the dorsal raphe elicits temporally distinct serotonergic responses in the limbic system in relation to fear behavior. Neuroscience 141, 1047-1055. (doi:10.1016/j.neuroscience.2006.04.006)
40. Burghardt NS, Bush DEA, McEwen BS, LeDoux JE. 2007 Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT2C receptor antagonist. Biol. Psychiat. 62, 1111-1118. (doi:10.1016/j.biopsych.2006.11.023)
41. Christianson JP, Ragole T, Amat J, Greenwood BN, Strong PV, Paul ED, Fleshner M, Watkins LR, Maier SF. 2010 5-Hydroxytryptamine 2C receptors in the basolateral amygdala are involved in the expression of anxiety after uncontrollable traumatic stress. Biol. Psychiat. 67, 339-345. (doi:10.1016/j.biopsych.2009.09.011)
42. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, Egan MF, Weinberger DR. 2002 Serotonin transporter genetic variation and the response of the human amygdala. Science 297, 400-403. (doi:10.1126/science.1071829)
43. Brown SM, Peet E, Manuck SB, Williamson DE, Dahl RE, Ferrell RE, Hariri AR. 2005 A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity. Mol. Psychiat. 10, 884-888+805. (doi:10.1038/sj.mp.4001725)
44. Hariri AR, Drabant EM, Munoz KE, Kolachana BS, Mattay VS, Egan MF, Weinberger DR. 2005 A susceptibility gene for affective disorders and the response of the human amygdala. Arch. Gen. Psychiat. 62, 146-152. (doi:10.1001/archpsyc.62.2.146)
45. Brown SM, Hariri AR. 2006 Neuroimaging studies of serotonin gene polymorphisms: exploring the interplay of genes, brain and behavior. Cogn. Affect. Behav. Neurosci. 6, 44-52. (doi:10.3758/CABN.6.1.44)
46. Munafo MR, Brown SM, Hariri AR. 2008 Serotonin transporter (5-HTTLPR) genotype and amygdale activation: a meta-analysis. Biol. Psychiat. 63, 852-857. (doi:10.1016/j.biopsych.2007.08.016)
47. Arce E, Simmons AN, Lovero KL, Stein MB, Paulus MP. 2008 Escitalopram effects on insula and amygdala BOLD activation during emotional processing. Psychopharmacology (Berl.) 196, 661-672. (doi:10.1007/s00213-007-1004-8)
48. Bigos KL, Pollock BG, Aizenstein HJ, Fisher PM, Bies RR, Hariri AR. 2008 Acute 5-HT reuptake blockade potentiates human amygdala reactivity. Neuropsychopharmacology 33, 3221-3225. (doi:10.1038/npp.2008.52)
49. Harmer CJ, Mackay CE, Reid CB, Cowen PJ, Goodwin GM. 2006 Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol. Psychiat. 59, 816-820. (doi:10.1016/j.biopsych.2005.10.015)
50. Sheline YI, Barch DM, Donnelly JM, Ollinger JM, Snyder AZ, Mintun MA. 2001 Increased amygdale response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol. Psychiat. 50, 651-658. (doi:10.1016/S0006-3223(01)01263-X)
51. Windischberger C et al. 2010 Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study. NeuroImage 49, 1161-1170. (doi:10.1016/j.neuroimage.2009.10.013)
52. Fales CL, Barch DM, Rundle MM, Mintun MA, Mathews J, Snyder AZ, Sheline YI. 2009 Antidepressant treatment normalizes hypoactivity in dorsolateral prefrontal cortex during emotional interference processing in major depression. J. Affect. Disord. 112, 206-211. (doi:10.1016/j.jad.2008.04.027)
53. Barnes NM, Sharp T. 1999 A review of central 5-HT receptors and their function. Neuropharmacology 38, 1083-1152. (doi:10.1016/S0028-3908(99)00010-6)
54. Riad M, Garcia S, Watkins KC, Jodoin N, Doucet E, Langlois X, el Mestikawy S, Hamon M, Descarries L. 2000 Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. J. Comp. Neurol. 417,181-194. (doi:10.1002/(SICI)1096-9861(20000207)417:2,181::AID-CNE4.3.0.CO;2-A)
55. Blier P, Pineyro G, el Mansari M, Bergeron R, de Montigny C. 1998 Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission. Ann. N Y Acad. Sci. 861, 204-216. (doi:10.1111/j.1749-6632.1998.tb10192.x)
56. Blier P, Bergeron R. 1995 Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J. Clin. Psychopharmacol. 15, 217-222. (doi:10.1097/00004714-199506000-00011)
57. Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ, Huang Y, Gautier C, Mathis C. 1999 PET imaging of serotonin 1A receptor binding in depression. Biol. Psychiat. 46, 1375-1387. (doi:10.1016/S0006-3223(99)00189-4)
58. Parsey RV, Oquendo MA, Ogden RT, Olvet DM, Simpson N, Huang Y-Y, Van Heertum RL, Arango V, Mann JJ. 2006 Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biol. Psychiat. 59, 106-113. (doi:10.1016/j.biopsych.2005.06.016)
59. Fisher PM, Meltzer CC, Ziolko SK, Price JC, Hariri AR. 2006 Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity. Nat. Neurosci. 9, 1362-1363. (doi:10.1038/nn1780)
60. Blakely RD, De Felice LJ, Hartzell HC. 1994 Molecular physiology of norepinephrine and serotonin transporters. J. Exp. Biol. 196, 263-281.
61. Rhodes RA, Murthy NV, Dresner MA, Selvaraj S, Stavrakakis N, Babar S, Cowen PJ, Grasby PM. 2007 Human 5-HT transporter availability predicts amygdala reactivity in vivo. J. Neurosci. 27, 9233-9237. (doi:10.1523/jneurosci.1175-07.2007)
62. Kobiella A. 2011 How the serotonin transporter 5-HTTLPR polymorphism influences amygdale function: the roles of in vivo serotonin transporter expression and amygdala structure. Transl. Psychiat. 1, e37. (doi:10.1038/tp.2011.29)
63. Jakab RL, Goldman-Rakic PS. 1998 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc. Natl Acad. Sci. USA 95, 735-740. (doi:10.1073/pnas.95.2.735)
64. Miner LAH, Backstrom JR, Sanders-Bush E, Sesack SR. 2003 Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex. Neuroscience 116, 107-117. (doi:10.1016/S0306-4522(02)00580-8)
65. Leysen JE. 2004 5-HT2 receptors. Curr. Drug Targets CNS Neurol. Disord. 3, 11-26. (doi:10.2174/156800 7043482598)
66. de Almeida J, Mengod G. 2007 Quantitative analysis of glutamatergic and GABAergic neurons expressing 5-HT2A receptors in human and monkey prefrontal cortex. J. Neurochem. 103, 475-486. (doi:10.1111/j.1471-4159.2007.04768.x)
67. Blue ME, Yagaloff KA, Mamounas LA, Hartig PR, Molliver ME. 1988 Correspondence between 5-HT2 receptors and serotonergic axons in rat neocortex. Brain Res. 453, 315-328. (doi:10.1016/0006-8993(88)90172-2)
68. Bhagwagar Z, Hinz R, Taylor M, Fancy S, Cowen P, Grasby P. 2006 Increased 5-HT2A receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with 11C.MDL 100,907. Am. J. Psychiat. 163, 1580-1587. (doi:10.1176/appi.ajp.163.9.1580)
69. Frokjaer VG et al. 2008 Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder. Biol. Psychiat. 63, 569-576. (doi:10.1016/j.biopsych.2007.07.009)
70. Stockmeier CA. 2003 Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J. Psychiat. Res. 37, 357-373. (doi:10.1016/S0022-3956(03)00050-5)
71. Weisstaub NV et al. 2006 Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science 313, 536-540. (doi:10.1126/science.1123432)
72. Fisher PM, Meltzer CC, Price JC, Coleman RL, Ziolko SK, Becker C, Moses-Kolko EL, Berga SL, Hariri AR. 2009 Medial prefrontal cortex 5-HT2A density is correlated with amygdala reactivity, response habituation, and functional coupling. Cereb. Cortex 19, 2499-2507. (doi:10.1093/cercor/bhp022)
73. Quirk GJ, Garcia R, Gonzalez-Lima F. 2006 Prefrontal mechanisms in extinction of conditioned fear. Biol. Psychiat. 60, 337-343. (doi:10.1016/j.biopsych.2006.03.010)
74. Azmitia EC, Gannon PJ, Kheck NM, Whitaker-Azmitia PM. 1996 Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology 14, 35-46. (doi:10.1016/S0893-133X(96)80057-1)
75. Amargos-Bosch M, Bortolozzi A, Puig MV, Serrats J, Adell A, Celada P, Toth M, Mengod G, Artigas F. 2004 Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. Cereb. Cortex 14, 281-299. (doi:10.1093/cercor/bhg128)
76. de Almeida J, Mengod G. 2008 Serotonin 1A receptors in human and monkey prefrontal cortex are mainly expressed in pyramidal neurons and in a GABAergic interneuron subpopulation: implications for schizophrenia and its treatment. J. Neurochem. 107, 488-496. (doi:10.1111/j.1471-4159.2008.05649.x)
77. Fisher PM, Price JC, Meltzer CC, Moses-Kolko EL, Becker C, Berga SL, Hariri AR. 2011 Medial prefrontal cortex serotonin 1A and 2A receptor binding interacts to predict threat-related amygdale reactivity. Biol. Mood Anxiety Disord. 1, 2. (doi:10.1186/2045-5380-1-2)
78. Sharp T, Boothman L, Raley J, Queree P. 2007 Important messages in the 'post': recent discoveries in 5-HT neurone feedback control. Trends Pharmacol. Sci. 28, 629-636. (doi:10.1016/j.tips.2007.10.009)
79. Holmes A. 2008 Genetic variation in corticoamygdala serotonin function and risk for stress-related disease. Neurosci. Biobehav. Rev. 32, 1293-1314. (doi:10.1016/j.neubiorev.2008.03.006)
80. Logothetis NK, Pauls J, Augath M, Trinath T, Oeltermann A. 2001 Neurophysiological investigation of the basis of the fMRI signal. Nature 412, 150-157. (doi:10.1038/35084005)
81. Fisher PM, Muñoz KE, Hariri AR. 2008 Identification of neurogenetic pathways of risk for psychopathology. Am. J. Med. Genet. C Semin. Med Genet. 148C, 147-153. (doi:10.1002/ajmg.c.30173)
82. Willeit M, Praschak-Rieder N. 2010 Imaging the effects of genetic polymorphisms on radioligand binding in the living human brain: a review on genetic neuroreceptor imaging of monoaminergic systems in psychiatry. NeuroImage 53, 878-892. (doi:10.1016/j.neuroimage.2010.04.030)
83. David SP, Murthy NV, Rabiner EA, Munafo MR, Johnstone EC, Jacob R, Walton RT, Grasby PM. 2005 A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J. Neurosci. 25, 2586-2590. (doi:10.1523/JNEUROSCI.3769-04.2005)
84. Aznavour N, Rbah L, Riad M, Reilhac A, Costes N, Descarries L, Zimmer L. 2006 A PET imaging study of 5-HT(1A) receptors in cat brain after acute and chronic fluoxetine treatment. NeuroImage 33, 834-842. (doi:10.1016/j.neuroimage.2006.08.012)
85. Paterson LM, Tyacke RJ, Nutt DJ, Knudsen GM. 2010 Measuring endogenous 5-HT release by emission tomography: promises and pitfalls. J. Cereb. Blood Flow Metab. 30, 1682-1706. (doi:10.1038/jcbfm.2010.104)
86. Licht CL, Marcussen AB, Wegener G, Overstreet DH, Aznar S, Knudsen GM. 2009 The brain 5-HT4 receptor binding is down-regulated in the flinders sensitive line depression model and in response to paroxetine administration. J. Neurochem. 109, 1363-1374. (doi:10.1111/j.1471-4159.2009.06050.x)
87. Finnema SJ, Varrone A, Hwang TJ, Gulyas B, Pierson ME, Halldin C, Farde L. 2010 Fenfluramine-induced serotonin release decreases [11C]AZ10419369 binding to 5-HT1B-receptors in the primate brain. Synapse 64, 573-577. (doi:10.1002/syn.20780)
88. Milak MS, DeLorenzo C, Zanderigo F, Prabhakaran J, Kumar JSD, Majo VJ, Mann JJ, Parsey RV. 2010 In vivo quantification of human serotonin 1A receptor using 11C-CUMI-101, an agonist PET radiotracer. J. Nucl. Med. 51, 1892-1900. (doi:10.2967/jnumed.110.076257)